Publication | Closed Access

Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1–positive advanced non–small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies

Elderly PatientsMedicinePembrolizumab MonotherapyClinical TrialsKeynote-042 StudiesImmune Checkpoint InhibitorPharmacotherapyCancer TreatmentOncologyRadiation OncologyLung CancerHealth Sciences